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under the CC BY-NC-ND license (http:Abstract Upper urinary tract urothelial carcinomas (UTUCs) are uncommon and account for
only 5%e10% of urothelial carcinomas. Pyelocaliceal tumors are about twice as common as ure-
teral tumors. Sixty percent of UTUCs are invasive at diagnosis. Radical nephroureterectomy,
including the excision of the distal ureter and bladder cuff is standard of care for treatment
of localized UTUCs, because of the high potential for recurrence, multifocality, and progres-
sion. Since first laparoscopic nephroureterectomy (LNU) was introduced by Clayman et al. in
1991 and improvement of laparoscopic technique and equipment, LNU has been reported to
be equivalent to conventional open method. We reviewed the current literature of patients
with UTUCs treated by LNU focusing on technical aspects, peri-operative and oncological out-
comes. Laparoscopic radical nephroureterectomy offers the advantages of minimally invasive
surgery without deteriorating the oncological outcome for treatment of UTUCs. Indications
tend to increase as operator skills increase. Indications for laparoscopic or open nephroureter-
ectomy are in principle the same. The basic requirement for laparoscopic surgery in UTUCs is
to achieve benefits of minimal invasive surgery and maintain oncologic principles.
ª 2016 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V. Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Upper urinary tract urothelial carcinomas (UTUCs) are
uncommon and account for only 5%e10% of urothelial(A.W. Chiu).
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//creativecommons.org/licenses/carcinomas (UCs) [1]. About 60% of UTUCs are invasive
at diagnosis compared with 15%e25% of bladder tumors [2].
Radical nephroureterectomy (RNU), including the exci-
sion of the ipisilateral distal ureter and bladder cuffity.
ion and hosting by Elsevier B.V. Ltd. This is an open access article
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UTUCs, because of the high potential for recurrence, mul-
tifocality, and progression. The first laparoscopic neph-
roureterectomy (LNU) was introduced by Clayman et al. in
1991 [3]. With the improvement of laparoscopic technique
and equipment, LNU has been reported to be equivalent
to conventional open method [4]. We reviewed the cur-
rent literature of UTUCs treated by LNU and focused on the
technical aspects, peri-operative and oncological
outcomes.
2. Access of laparoscopy
During this contemporary 10-year study, minimal invasive
nephroureterectomy (miNU) is replacing open surgery for
UTUC [5]. LNU can be performed via a transperitoneal or a
retroperitoneal access in a pure laparoscopic, hand-assisted
or robotic-assisted laparoscopic technique.
Experienced surgeons may prefer the pure laparoscopic
technique. The hand-assisted surgery represents a compro-
mise between open and laparoscopic approach. The advo-
cates of the hand-assisted technique emphasize the shorter
learning curve of the procedure as well as the ability of
palpation. This approach affords the use of tactile sensation,
blunt manual dissection, and broad retraction with the
manipulation. It also decreases operative time and allows
surgeons to performminimally invasive procedures for larger
and more extensive tumors [6].
Recently, the da Vinci robot system (Intuitive Surgical,
Sunnyvale, CA, USA) was introduced for surgeons to
perform laparoscopic operations more easily by reducing
the technical difficulty of intracorporeal suturing. The first
case of robot-assisted NU (RANU) for left ureteral UC un-
dergone via a retroperitoneal approach was reported by
Rose et al. [7] in 2006. In recent, we observed that the
practice of robot-assisted surgery in the treatment of many
genitourinary diseases including UTUCs expanded exten-
sively. The robot was most useful during the regional lym-
phadenectomy and suturing of the cystotomy after excision
of the distal ureter [8]. However, the current data do not
show any significant difference regarding peri-operative
outcomes and postoperative morbidity when comparing
these techniques.
As to the access of laparoscopy, the advantages of a
transperitoneal approach compared to a retroperitoneal
approach include a familiarity with anatomic landmarks
and a larger working space. The retroperitoneal approach,
however, has distinct advantages, including early control of
the renal artery and vein, no manipulation of the bowel
leading to less incidence of ileus and confinement of
possible urinoma or seromas to the retroperitoneal space.
As such, the retroperitoneal approach has the advantage in
terms of quicker bowel recovery and shorter hospital stay
[9]. More or less both transperitoneal and retroperitoneal
laparoscopic approaches are considered as safe and effec-
tive methods for the treatment of UTUCs.
3. Distal ureterectomy and BCE techniques
The ideal nephroureterectomy procedure is to remove the
entire ipsilateral urinary tract in continuity while avoidingextravesical transfer of tumor-containing urine during the
part of excision of bladder cuff, in an acceptable opera-
tive time with the least surgical complications [10].
Resection of the distal ureter and its orifice should be
performed because there is a considerable risk of tumor
recurrence in this area. After removal of the proximal
ureter, it is difficult to image or approach it by endos-
copy. Removal of the distal ureter and bladder cuff is
beneficial after RNU [11,12]. However, the techniques of
this part is the most diverse, thereby there is still lack of
consensus regarding the optimal approach to the bladder
cuff so far.
Several techniques for the resection of the distal ureter
and bladder cuff have been described and they can be
performed through a transvesical, extravesical, or endo-
scopic approach and the optimal approach still does not
reach a consensus. Currently, these methods include open
excision via a Gibson incision, transurethral resection (TUR)
of ureteral orifice (pluck technique), ureteric intussuscep-
tion, and pure laparoscopic or pure robotic-assisted lapa-
roscopic resection techniques [13].
To compare the oncologic effectiveness of different
surgical approach for BCE, Xylinas et al. [14] retrospec-
tively analyzed 2681 patients who were treated with RNU
with transvesical, extravesical, or endoscopic BCE. They
found that there are no differences in extra-bladder
recurrence and survival between transvesical, extra-
vesical, and endoscopic management of the bladder cuff
but the endoscopic approach results in higher intravesical
bladder cancer recurrences. The transvesical approach
guarantees precise distal ureter and BCE after preventive
ureteral occlusion but it violates the bladder integrity in
both cystotomy and BCE site in patients with a UTUCs.
Therefore, an anterior cystotomy must be eschewed when
there is an active bladder UC [15].
The pluck technique has been suggested to be oncolog-
ically safe in patients with proximal, low-grade UTUCs [12].
But this technique is not suitable for tumors or multifocal
disease involving the lower ureter or the uretero-vesical
junction or widespread carcinoma in situ due to the like-
lihood of tumor seeding, risk of local recurrence, and pos-
itive surgical margins [16]. Oncological concerns remain if
the ureter is not occluded before resection, due to the risk
of tumor spillage or retroperitoneal recurrences. To avoid
these drawbacks, various modifications of ureteral occlu-
sion have been suggested [17,18].
Pure LNU and RANU includes the techniques of laparo-
scopic dissection with either extravesical stapling of the
distal ureter or complete laparoscopic dissection and
resection of the whole kidney, ureter and bladder cuff,
then suturing reconstruction of the bladder cuff area. The
trocar configuration is similar to laparoscopic nephrectomy
trocar deployment pattern, except that all the trocars are
moved slightly caudally for better access to the distal
ureter and bladder cuff.
Laparoscopic dissection with extravesical stapling of the
distal ureter avoids cystotomy, however, this technique
risks leaving viable ureteral mucosa and it may result in
greater positive margin rate. In addition, staples may
remain exposed within the bladder predisposing to stone
formation, while the stapled margin cannot be assessed
histologically [19,20].
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forming a distal ureterectomy and proper BCE, the re-
positioning, re-docking of the robot and in some instances,
re-preparing the patient, all may result in a more lengthy
operation.
Ritch et al. [21] performed a retrospective analysis on
36 patients comparing the open resection technique versus
the laparoscopic extravesical stapling approach versus
total laparoscopic dissection and suture reconstruction
of ureter and bladder cuff. The results of this study
showed that laparoscopic stapling and complete laparo-
scopic resection of distal ureter and suture reconstruction
had significantly shorter operative time and hospital stay
compared with the open resection technique. Neverthe-
less, a cystoscopically appreciable remnant of the resec-
ted ureteral orifice was noted in 50% of the laparoscopic
stapling cohort versus none with the open resection or
complete laparoscopic resection of distal ureter and
suture reconstruction cohorts. The authors concluded that
all patients with bulky distal ureter disease must continue
to be treated with an open bladder cuff resection tech-
nique, while patients with low-stage, low-grade disease
are preferentially treated with a total laparoscopic
resection.4. Role of lymphadenectomy
Lymphovascular invasion (LVI) was considered as an inde-
pendent predictor of poor outcome [22]. However, per-
forming lymph node dissection (LND) is surgeon dependent.
The templates for LND was suggested by Kondo and col-
leagues [23] according to the tumor location, and they
interestingly found that in patients with muscle-invasive
clinical node-negative UTUCs, the survival of the patients
were influenced by the type of the templates but not the
numbers of removed nodes.
To emphasize the importance of LND in the treatment
of UTUCs, Abe et al. [24] retrospectively reviewed a cohort
of 293 patients with UTUCs who underwent predominantly
NU for localized disease. A total of 76 patients developed
disease relapse. Regional lymph node recurrence was
the most common site in 34 patients. On multivariate
analyses that adjusted for the effect of tumor stage and
tumor grade, pNx which meaned that LND was not done
during the procedure was an adverse factor not only for
regional recurrence, but also for distant relapse. Even
more, immunohistochemistry identified micrometastases
in seven (14%) of 51 patients who were previously diag-
nosed as pN0 [24]. These findings further suggested
a potential therapeutic benefit of LND by eliminating
micrometastases.
However, in the study by Lughezzani and colleagues [25]
analyzing 2824 patients from the SEER database, LND
showed no benefit in patients with N0 status compared with
Nx status. In addition, Roscigno et al. [26] addressed
cancer-specific survival according to lymph node status at
radical nephroureterectomy for UTUCs. They suggested
that LND should be performed in patients with suspected
pT2-4 stages, to improve the prediction of the natural his-
tory of surgically treated UTUCs and to use this information
for possible adjuvant chemotherapy.To conclude, the benefit of LND at RNU has been shown
for locally advanced tumor stages and should be considered
in all such cases [27]. Therefore, LND has been suggested
to be curative in cases of limited nodal invasion and should
be performed in patients with clinically positive regional
nodal disease in the absence of distant metastases. Thus,
the performance of LND per se seems to be prognostically
beneficial.
The role of retroperitoneal lymph node dissection
(RPLND) for UTUCs has been evolving in parallel with
the technique of RNU. Melquist et al. [28] introduced single-
docking RNU-RPLND, which offers a streamlined approach
for this multicomponent operation, which may have broader
implications in the oncologic management of patients.
However, better designed prospective trials are still needed
to standardize the indications for LND and to determine
which lymph nodes should be removed according to different
tumor locations within the urinary tract. Precise templates
need to be established for each tumor location.
5. Peri-operative outcomes
Benefits of minimally invasive surgery included less blood
loss, decreased postoperative narcotic use, and shorter
hospital stay [5]. Jens et al. [29] and Shaobin et al. [4] both
reported a systemic review and cumulative analysis of
available comparative studies on comparison of laparo-
scopic and open nephroureterectomy for UTUCs. The
analysis revealed a slightly longer OR-time (276.6 vs.
220.1 min), and significantly lower blood loss (240.9 vs.
462.9 mL) in the laparoscopic series. No differences of
minor (12.9% vs. 14.1%) or major complication rate (5.6% vs.
8.3%) were observed. Comparative studies revealed a sig-
nificant dose reduction of the morphine-equivalents and
shorter hospital stay after laparoscopy.
6. Oncological outcomes
In early experience, it postulated initially that the high-
pressure environment of the pneumoperitoneum might
exacerbate tumor dissemination and result in a higher rate
of recurrence [30]. There have been reports of retro-
peritoneal metastatic dissemination and/or dissemination
along the trocar pathway when large tumors have been
manipulated in a gas environment. Cases of peritoneal
cancer dissemination or early metastases at unusual met-
astatic sites have been reported but always for high-grade
invasive tumors [30].
However, recent advances in technology and experi-
ences on laparoscopy have challenged the concepts. Ac-
cording to a systemic review and cumulative comparative
studies, Jens et al. [29] reported that 21 eligible studies
(1235 cases and 3093 controls) were identified. Although a
significantly higher proportion of pTa/Tis was observed in
LNU compared to open nephroureterectomy (ONU) (27.52%
vs. 22.59%; p Z 0.047), yet there were no significant dif-
ferences in other stages and pathologic grades (all p > 0.05)
[4]. In conclusion, there were no statistically significant
differences in 2-year cancer specific survival, 5-year
recurrence-free survival (RFS), 5-year overall survival
(OS), 2-year OS, and metastasis rates [4,31].
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As in the majority series, predominantly non-invasive tu-
mors (pTa/pT1) have been treated laparoscopically, and
some recommend that invasive, large (T3/T4 and/or Nþ/
Mþ), or multifocal tumors should be contraindications to
LNU despite the eagerness of patients for minimally inva-
sive surgery [32,33]. It is worth noting that indications tend
to increase as operator skills increase. Oncological outcome
of LNU is no inferior to that of ONU in muscle-invasive
UTUC, when the appropriate patients are selected [34]. It
indicated that the most important principle is to maintain
oncologic principles and duplicate established open surgical
techniques.
8. Conclusion
Laparoscopic radical nephroureterectomy offers the ad-
vantages of minimally invasive surgery without deterio-
rating the oncological outcome for treatment of UTUCs.
Indications of LNU tend to extend to the advanced disease
with the operator skills improving. The current challenges
remain the choice of a way to undergo distal ureterectomy
and BCE. The optimal approach depends on the experience
of the surgeon and further confirmation about which is the
best one still waits more clinical investigations.
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